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Abstract
Objective: To evaluate the Patient Care Monitor (PCM1.0) Acute Distress and Despair
normalized T scores as indicators of a diagnosis of Major Depression according to the
Structured Clinical Interview for DSM-IV Axis I Disorders (SCID).
Methods: Subjects were 21 adult cancer patients identiﬁed by treating community
oncologists as having signiﬁcant emotional distress matched on age, cancer type, treatment
history, and sex to 21 patients not having signiﬁcant distress. All completed e/tablet PCM 1.0
and SCID administered by trained interviewers. Unweighted kappa and receiver operating
characteristics (ROC) analyses were used to assess scale properties.
Results: Agreement between SCID Major Depression and Acute Distress and Despair
(TX65) were kappa 5 0.751 and 0.755, respectively. ROC area under the curve values for
these two scales were 0.967 (SE70.03) and 0.942 (SE70.03), respectively, with optimal cut
points of T 5 61 and 63, respectively.
Conclusions: Under conditions of preselected extreme groups, PCM 1.0 Acute Distress
and Despair T scores are reasonable screening indicators of clinical depression in cancer
patients. PCM 1.0 provides an eﬃcient method for point-of-care screening of depression in
community oncology clinics.
Copyright r 2009 John Wiley & Sons, Ltd.
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Objective
Cancer patients often experience psychological
diﬃculties, including sadness, grief, anxiety, irritability, guilt, sleep disturbance, and poor concentration. Although the majority manages their
symptoms adequately, some experience signiﬁcant
diﬃculties that may interfere with medical treatment [1]. Prevalence rates of depression have been
diﬃcult to estimate due to variations associated
with screening methods, disease characteristics,
and patient age [2]. Coyne and his colleagues
reported that 9% of breast cancer patients met
diagnostic criteria for Major Depression when
structured clinical interviews were used [3]. This is
slightly higher than the 12 months general population prevalence rate of 6.6% [4]. Interview-based
estimates of anxiety disorders suggest that such
problems occur in about 7% of cancer patients,
and it is not uncommon for both problems to be
present in the same patient [2]. Because of the
potential for negative impact on quality of life
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(QoL) and delivery of medical treatment, it is
important to screen for such problems.
Eﬃcient and eﬀective screening for clinical
depression and anxiety is complicated by the fact
that it is normal for cancer patients to have higher
than average levels of distress. Routine use of
measures that primarily assess severity of distress
as compared with normal or even mental health
service seeking populations can over identify
problems in cancer patients [5]. Measures are
needed that compare cancer patients to a normative group of cancer patients.
Another diﬃculty is the strong correlation
between measures of depression and anxiety. If a
set of questions measures generalized distress or
undiﬀerentiated negative emotion, as most do, then
it will fail to discriminate between Major Depression and anxiety disorders. This necessitates further
action to make the distinction. Clark and Watson
have noted that the key to diﬀerentiation is to have
some measure of positive aﬀect. This permits one
to identify loss of positive aﬀect among depressed
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patients and to distinguish that feature from
physical tension and hyper arousal, which is the
most prominent feature of anxiety [6].
Several instruments have been developed to
address the challenge of evaluating psychological
diﬃculties in cancer patients. Much of this work
has advocated for a primary focus on undiﬀerentiated emotional distress [7]. The Distress
Thermometer (DT) was developed as a single item
indicator of undiﬀerentiated distress [8]. Currently,
the National Comprehensive Cancer Network
recommends that the DT be administered along
with a 35-item list of problems [9]. This adds
important detail but also undermines the brevity of
the instrument, a factor that is important in how
acceptable a physician will ﬁnd an instrument for
routine use [10].
To use technology to support brief and eﬃcient
questionnaire administration, researchers have
promoted the use of e/tablet computers [11–14].
This enables patients to report their symptoms
while waiting for their physician and simultaneously reduces staﬀ workload through automated
scoring and report generation. Quality of life
assessment via e/tablet can also eliminate problems
with omitted or invalid item responses and has
been found to be a reliable method of assessment
[14]. Furthermore, screening measure completion
through e/tablet computers has been reported to be
an easy task for patients, even when they are
beginner level computer users [11,12].
The Patient Care Monitor 1.0 (PCM 1.0;
formerly called Cancer Care Monitor) is an
assessment tool designed to be integrated into
clinical practice through use of pen-based e/tablet
computers that collect, analyze, score, summarize,
and deliver patient-reported outcomes to clinicians
within minutes [15,16]. The PCM 1.0 comprises six
primary symptom scales and one global QoL
index. By providing a means to track the scores
of patients over time, physicians are better
equipped to take preventative steps with high risk
patients and to monitor patients. In a preliminary
study of the PCM 1.0, the Acute Distress and
Despair scales were strongly associated with a
validated measure of psychological distress in
cancer patients [16]. Accordingly, the Acute Distress and Despair scales of the PCM 1.0 may be
useful tools to screen for cancer patients who are
likely to be suﬀering from Major Depression.
The objective of this study was to evaluate
the Acute Distress and Despair scales of the PCM
1.0 as practical screening procedures to identify
clinical depression in cancer patients who were
selected to be at either high or low risk for
depression as judged by their medical oncologists.
In this study, the Structured Clinical Interview
for DSM-IV Axis I Disorders (SCID) served as
‘‘the gold standard’’ for the diagnosis of psychiatric
disorder [17].
Copyright r 2009 John Wiley & Sons, Ltd.
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Methods
Participants
Participants were (N 5 42) volunteer adult cancer
patients recruited from 1 January 2001 to 31 May
2002 from a large oncology practice, West Clinic,
Memphis, TN. West Clinic serves patients with a
wide variety of cancer types, but breast cancer is
predominant, accounting for approximately 60%
of cases. Participants’ demographic characteristics
are reported in detail below. Patients who agreed
to participate were provided with a brief explanation of the purpose of the study and the rights
of participants. All participants signed informed
consent forms approved by the University of
Memphis Institutional Review Board. All were
paid $25.00 for their participation. Research staﬀ
and medical staﬀ were integrated into the clinic and
trained in HIPAA procedures. All patients were
informed about the practice of communication
between clinical and research staﬀ and gave
permission for such protected communication.

Design and procedures
For this study, two samples were recruited.
Recruitment for both samples took place concurrently. In order to create an expedited sample of
patients who were likely to suﬀer from clinically
signiﬁcant distress, the recruitment procedure
relied on referrals from physicians. Referrals were
requested at three diﬀerent meetings, where physicians were asked to identify patients they thought
were more depressed than nervous, as well as
contrasting patients who they thought were likely
to be free from signiﬁcant emotional distress.
The ﬁrst group (n 5 21) comprised patients identiﬁed by their oncologist as likely to be suﬀering
from signiﬁcant emotional distress. Physicians were
informed about the approval for the study and
were asked to work with research staﬀ to introduce
the purpose of the study and to facilitate contact
with the research staﬀ when a prospective patient
indicated interest. Treating physicians made the
initial contact with the patient. With such direct
physician involvement, only three prospective
participants declined the invitation to be in the
study after the patient met with the research staﬀ.
The second sample of patients (n 5 21) was
collected as a comparison group and consisted of
individuals who were likely to be free from
signiﬁcant emotional distress. This group was
matched to the ﬁrst group on several key variables
including age, cancer type, treatment history, and
sex. Prospective patient volunteers from this group
were identiﬁed by appointment records to determine match on key variables, and their physicians
were then contacted to assist with introducing the
study. Similar to procedures used to recruit the ﬁrst
group, patients’ physicians were contacted to
Psycho-Oncology 19: 399–407 (2010)
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determine whether the individuals appeared to be
free of any signiﬁcant emotional distress. From this
subject recruitment process, nine patients refused
to participate in the research.
Those agreeing to participate in the study
completed the electronic tablet computer administered (e/tablet) version of the Patient Care Monitor
as well as an identifying information form. Average
completion time for the PCM 1.0 was under
3.5 min, with ﬁrst time use slightly longer at less
than 5 min. As might be expected, introduction to
the PCM 1.0 requires some brief acculturation, but
no signiﬁcant diﬃculties completing the measure
were reported. Following this, advanced doctoral
students in clinical psychology, who had been
trained to administer the SCID, conducted SCID
interviews with all participants. These interviews
typically lasted approximately 45 min to 1 h for
patients who endorsed many symptoms. Because
the SCID is hierarchical and permits skipping of
items, interviews with patients who endorsed no
symptoms typically lasted less than 20 min. Interviewers were not informed of the status of the
patient being interviewed. Participants in both the
groups completed the forms and the SCID interview in the same order.
Five advanced graduate students in clinical
psychology completed approximately 100 h of
intensive training in the SCID interview procedure.
Training also emphasized identiﬁcation of cancer
disease and treatment-speciﬁc conditions that
might lead to diagnosis of an Axis I disorder
attributable to a general medical condition. Interviewers consulted treating oncologists and nurse
practitioners whenever such questions arose. Role
play was used to assess inter-rater reliability during
practice sessions, and raters were trained to a
criterion of kappa for Axis I diagnosis X0.85.
As a further check on inter-rater reliability, we
randomly selected ﬁve cases from each group to
have a second interviewer present during the SCID.
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The second interviewer only interacted with the
patient if he or she needed clariﬁcation for a
speciﬁc patient response beyond that elicited by the
primary interviewer. Paired interviewers were
seated so that they could not observe how each
was completing the paper version of the SCID
protocol.

Measures
Identifying information

Participants provided basic background and demographic information, such as date of birth, sex,
diagnosis, date of diagnosis, marital status, ethnic
background, level of education completed, and
household income. Research assistants reviewed
medical charts to verify date of birth, medical
diagnosis, date of diagnosis, stage at diagnosis, and
treatment received.
Patient care monitor (PCM 1.0, formerly called cancer
care monitor [CCM])

PCM 1.0 comprises 38 patients reported outcome
items that are administered serially on a touch
screen-based tablet computer as illustrated in
Figure 1. Each item is presented so that the patient
rates the degree to which the item has been a
problem in the past week using a 0–10 scale of
severity (0 not a problem to 10 as bad as possible).
The instructions are: ‘Touch the red dot on the line
that best describes how bad the symptom has been
for you during the past week including today’.
PCM 1.0 was validated in comparison with a
series of symptom and health-related QoL measures
[16] including: Brief Symptom Inventory [18],
Medical Outcomes Study SF-36 Health Survey
(SF-36) [19,20], Memorial Symptom Assessment
Scale [21], Life Satisfaction Index-Short Form
[22,23], and Satisfaction with Life Scale
[24,25]. PCM 1.0 yielded six scales: General

Figure 1. Patient Care Monitor (PCM 1.0) item for fatigue (tiredness) with response scale presented on e/tablet
Copyright r 2009 John Wiley & Sons, Ltd.
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Physical Symptoms (11 items), Treatment Side Eﬀects
(8 items), Acute Distress (4 items), Despair (7 items),
Impaired Ambulation (4 items) Impaired Performance
(4 items). The internal consistency reliabilities ranged
from 0.80 to 0.89 (Cronbach’s alpha). In addition to
the six scales PCM 1.0 also yielded an overall healthrelated QoL Index. Each of the six scales and QoL
Index can be reported as normalized T scores (Mean
50, SD 10) based on a standardization sample of 449
adult cancer patients. The pattern of concurrent
validity coeﬃcients supported the validity of the six
scales and QoL Index of the PCM 1.0 [16]. The
present study used only the acute distress and despair
subscales.
A unique feature of the PCM 1.0 scale sores is
that they can be expressed as normalized T scores
with a mean of 50 and standard deviation of 10.
The normative group consisted of 449 diverse
cancer patients who participated in the psychometric validation study of the PCM 1.0 [16]. This
method of scale construction means that a T score
greater than or equal to 65 places the individual at
the 95th percentile or above relative to the
reference group of heterogeneous cancer patients.
A T score X65 on Acute Distress or Despair means
that the individual with that score falls at the
extreme end of a normalized distribution of scores
relative to cancer patients. The PCM 1.0 Acute
Distress and Despair scales were designed to assess
anxiety and depression with speciﬁc reference to
cancer patients as the normative group.
The PCM 1.0 is also acceptable to patients and
economically sound for physicians. With regards to
patient acceptability, a key to compliance is having
their physician endorse and then use the measure
during visits. For patients who know that their
physician will use the measure, compliance is well
above 95%. With regards to economic feasibility,
the current version of the PCM (PCM 2.0, Acute
Distress and Despair scales unchanged) has shown
an ability to pay for itself within 2 years. PCM
results can supplement documentation of a full
review of systems, which permits physicians coding
for a higher level visit.
Structured clinical interview for DSM-IV axis I disorders (SCID)

The SCID is a structured clinical interview to
determine psychiatric diagnoses for Axis I of the
Diagnostic and Statistical Manual of Mental
Disorders (DSM) fourth edition [26]. It is regarded
as the gold standard for mental health diagnosis.
The SCID is administered hierarchically; if an item
is endorsed, the interviewer seeks additional details. If an item is not endorsed, the interviewer
moves forward to subsequent items. A specially
modiﬁed version of the SCID, the SCID NonPatient edition, designed for research with primary
care populations was used for cancer patients in
Copyright r 2009 John Wiley & Sons, Ltd.

A. C. Houts et al.

a primary medical setting [17,27]. The SCID was
designed in modules to be modiﬁed for speciﬁc
purposes of a study. The modules of the SCID used
in the present study were: Screener items for drug
and alcohol abuse (1 page), Mood Episodes
(46 pages), Psychotic Screener (3 pages), Mood
Diﬀerential (11 pages), Adjustment Disorder
(2 pages), Acute Stress Disorder (7 pages), and
Anxiety Disorders (41 pages). Altogether, this
version of the hierarchical, research-based SCID
covered a total of 521 possible questions.

Statistical analyses
To check comparability of basic demographic
information from the matching procedures used
for groups, we conducted t-tests for continuous
variables and chi square tests for categorical
variables. Inter-rater agreement using unweighted
kappa for Axis I diagnosis was computed for the
subsample of patients where there were two
interviewers present for the SCID administration.
Unweighted kappa was also computed for the
categorical agreement for the presence or absence
of anxiety disorder or mood disorder as determined
by SCID versus, respectively, PCM 1.0 T score X65
on the Acute Distress or Despair scales. We also
used receiver operating characteristics (ROC)
analysis to examine diﬀerent T score cut points
on the Acute Distress and Despair scales to
maximize sensitivity and speciﬁcity under the
assumption that the SCID determination of the
presence or absence of disorder was the gold
standard for diagnosis.

Results
Table 1 shows demographic characteristics of the
two patient groups. Referrals for the study came
from ﬁve diﬀerent physicians. Analysis of patient
demographics and disease characteristics by physician showed no signiﬁcant diﬀerences among
patients according to referring physician.
As might be expected from matching procedures,
there were no statistically signiﬁcant diﬀerences
between the groups on demographic descriptors
(all p’s40.20). Patients were predominantly female
with average age of 55 years old. They were also
predominantly Caucasian/Not Hispanic with a
small minority of African Americans, and over
90% reported education at or beyond high school
graduation. Over three fourths were married, and
over half reported annual household incomes
above $30 000. Table 1 also shows disease-related
characteristics for the two groups. Patients in both
samples had a variety of cancer diagnoses, with
breast cancer the largest proportion followed by
lymphoma. A majority in both groups had not
received treatment in the immediate preceding
Psycho-Oncology 19: 399–407 (2010)
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Table 1. Demographic, disease, and previous treatment characteristics of matched adult cancer patients identified by
treating oncologists as either having or not having significant
emotional distress

Mean Age in years (range)
Female
Ethnic background
Black/African American
American Indian/Alaskan Native
Caucasian/Not Hispanic
Education X12 years
Marital status
Married
Single
Divorced
Widowed
Household incomea
Under 15K
15–29 999K
30–49 999K
50–74 999K
75–99 999K
100–149 999K
Over 150K
Cancer type
Breast
Gastrointestinal
Lung
Lymphoma
Other diagnoses
Treatments in past 3 months
Surgery
Chemotherapy
Radiation
Hormonal therapy
None in past 3 months

Patients with
distress
(n 5 21)

Patients without
distress
(n 5 21)

53.0 (21–80)
71.4 %

57.0 (32–81)
76.2 %

9.5
0.0
90.5
90.5

19.0
4.8
76.2
100.0

76.2
9.5
14.3
—

81.0
9.5
—
9.5

10.0
20.0
25.0
20.0
10.0
15.0
—

15.8
10.5
15.8
36.8
10.5
5.3
5.3

38.1
14.3
9.5
23.8
14.4

38.1
14.3
9.5
23.8
14.4

0.0
33.3
4.8
4.8a
61.9

4.8
19.0
14.3
10.5a
65.0a

3 months, and among those who did, chemotherapy was the most frequent of recent treatments.
Again as would be expected from matching
procedures, there were no signiﬁcant diﬀerences
between the two samples on types of cancer and
previous treatment (all p’s40.20).

SCID results

Note. Values are percentages unless otherwise designated. Patients in the ‘without
significant emotional distress group’ were matched to patients in the ‘with
significant emotional distress group’ on the following characteristics: age, cancer
type, treatment history, and sex.
a
One participant did not provide information.

To assess inter-rater reliability, we randomly
selected 25% of the SCID administrations (n 5 5
for each group) for a reliability check. These
administrations were conducted with two interviewers present, with one acting as the primary
interviewer and the second participating only when
necessary to clarify patient responses. The unweighted kappa obtained for the Axis I diagnoses
was 1.0.
None of the patients in the group selected by
their physicians as being free of signiﬁcant emotional distress met criteria for an Axis I diagnosis
based on the SCID administration. Table 2 shows
the Axis I diagnoses of the 21 patients identiﬁed as
having signiﬁcant emotional distress. Of the 21, 19
(91%) met criteria for Major Depression, but
among those, 2 were diagnosed as in full remission
from a previous episode. Therefore, in subsequent
analyses only 17 of the 21 patients from this group
were treated as meeting SCID criteria for current
Major Depression. As shown in Table 2, two
patients received primary diagnoses other than
depression, one for Opioid-Induced Mood Disorder, and another for Generalized Anxiety Disorder. Also among the 8 patients with a primary
diagnosis of Major Depressive disorder, recurrent,
and severe, 4 (19%) had a dual diagnosis of an
anxiety disorder (Generalized Anxiety Disorder,
Panic Disorder with Agoraphobia, Panic Disorder
without Agoraphobia and Obsessive–Compulsive
Disorder), and one patient among those 4 also met

Table 2. Number of Axis I disorders diagnosed from the Structured Clinical Interview for DSM-IV Axis I disorders 21 cancer
patients identified by treating oncologists as having significant emotional distress
Primary diagnosis
Major depressive disorder, recurrent
Severe without psychotic features (296.33)
Major depressive disorder, single episode
Severe without psychotic features (296.23)
Major depressive disorder, single episode
Moderate (296.22)
Major depressive episode, single episode
in Full Remission (296.26)
Major depressive episode, recurrent,
Mild (296.31)
Major depressive episode, recurrent,
Moderate (296.32)
Opioid-induced mood disorder (292.94)
Generalized anxiety disorder

Copyright r 2009 John Wiley & Sons, Ltd.

n
8
4

Second diagnosis
Generalized anxiety disorder
Panic disorder with agoraphobia
Panic disorder without agoraphobia
Obsessive compulsive disorder

Third diagnosis

Social phobia

3
2
1
1
1
1
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criteria for a diagnosis of Social Phobia. With only
one case given a primary diagnosis of anxiety
disorder in this sample, we focused additional
analyses on Major Depression only.

PCM 1.0 acute distress and despair related to
SCID diagnosis
We examined the commonly used cut points of
normalized T scores X65 for Acute Distress and
Despair scales of the PCM 1.0 for agreement with
mood disorder diagnoses based on SCID interviews. Considering the 17 cases of SCID identiﬁed
current Major Depression, unweighted kappas
were: Acute Distress, 0.751 and Despair, 0.755.

ROC analysis
We used ROC analysis of the overall sample
(N 5 42) to examine various T score cut points of
the Acute Distress and Despair scales as accurate
indicators of current Major Depression determined
by the SCID. ROC analysis produces a range of
cutoﬀ scores from the minimum observed value to
the maximum observed test value. For each cutoﬀ
value, the ROC curves plot true positive rate
(sensitivity) on the y-axis against the false positive
rate (1-speciﬁcity) on the x-axis to produce a plot
showing how well the test separates the participants
into those with or without a diagnosis. To assess the
accuracy of the measure, the ROC analysis produces
a statistic called area under the curve (AUC), which
ranges from 0 to 1. An AUC of 0.50 represents
diagnostic performance equal to chance and AUC
of 1 represents perfect diagnostic performance.
Figures 2(a) and (b) show the ROC curves,
respectively, for the Acute Distress and the Despair
scales. The AUC for Acute distress was 0.967
(SE10.03) and for Despair was 0.942 (SE10.03).
We also used ROC analysis to identify speciﬁc
cutoﬀ scores for both the Acute Distress and
Despair subscales as shown in Table 3. To identify
the point where sensitivity and speciﬁcity were both
maximized, we calculated Youden’s Index [28]. The
highest Youden Index for the Acute Distress was
0.84, corresponding to a T score of 61, and for
Despair the index was 0.78, corresponding to a
T score of 63.

Conclusions
This study provided an initial examination of the
utility of the PCM 1.0 as a brief, easily administered screening tool to identify possible cases of
clinical depression in cancer patients who were
selected to be at either high or low risk for clinical
depression. PCM 1.0 Acute Distress and Despair
scales were designed to measure anxiety and
depression with speciﬁc reference to cancer patients
Copyright r 2009 John Wiley & Sons, Ltd.
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as the normative group. Under these ideal conditions of patient selection, ROC analysis showed
that normalized T scores greater than 61 and 63,
respectively, for Acute Distress and Despair can
accurately discriminate patients who received
a diagnosis of Major Depression from those
who did not. Using the conventional T score
cutpoint of 65 or greater, chance adjusted agreement between SCID diagnosis and scale scores
exceeded 0.70, a threshold generally regarded as
acceptable to good [29].
Previous psychometric research has suggested
that while the Acute Distress and Despair scales are
highly correlated (r 5 0.70), they also may emphasize diﬀerent aspects of psychological distress,
anxiety and depression, respectively [16]. However,
within the current study the two scales did not
show evidence for diﬀerential discriminant ability
to screen for Major Depression. Surprisingly, the
Acute Distress scale was a slightly better indicator
of Major Depression than the Despair scale. This
may have been due to the small sample size and the
fact that among the few patients who did receive an
anxiety-related diagnosis most also received a dual
diagnosis of Major Depression. Depending on the
context in which the PCM 1.0 is used, this may not
be problematic. The appropriate role of a brief
screening instrument is to identify which patients
warrant further attention in the form of clinical
interview. Accordingly, it would be unwise to
assume that the PCM 1.0 scales can be used to
make accurate diﬀerential diagnosis.
The situation is likely to arise in which a patient
scores above the cutoﬀ score on one of the scales,
but not the other. Accordingly, it is appropriate to
consider the appropriate course of action in this
situation. Because both the Acute Distress scale
and the Despair scale are shown to have the ability
to screen for possible cases of Major Depression, it
is advisable to follow up with a clinical interview
when a patient has exceeded the cutoﬀ score for
either of these scales. Owing to the signiﬁcant
impact of Major Depression on a patient’s life, this
extra caution is warranted. Future research may
allow for greater discrimination to be made in the
decision-making process.
A major limitation of the current sample was
that it represented extremes of psychological
diﬃculty among the general cancer population.
Additionally, the study included primarily Caucasian females. It remains for further research to
determine how well the PCM 1.0 Acute Distress
and Despair scales will perform in unselected and
more diverse samples of adult cancer patients.
Future research should expand the scope of the
present study by determining the sensitivity and
speciﬁcity of the scales using a larger sample of
patients who have not been pre-screened for
psychological distress. Such analyses should also
be conducted across clinical characteristics such as
Psycho-Oncology 19: 399–407 (2010)
DOI: 10.1002/pon
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Figure 2. Receiver operating characteristic curves of the PCM 1.0 acute distress: (a) despair and (b) scales to detect current major
depression from structured clinical for DSM-IV Axis I disorders among 42 select adult cancer patients

type and stage of cancer, treatment modality, and
presence of metastasis.
Whereas matching strategies were used across
groups, it is important to recognize that it is not
possible to control for all of the potentially
important diﬀerences that inevitably exist between
these groups. Some important diﬀerences that were
not controlled include: prior psychiatric history,
social and family support, and ﬁnancial circumstances. Because more than half of the 21 patients
in the distressed group were found in retrospect to
have had a history of a psychiatric disorder (i.e. 10
patients were diagnosed with recurrent MDD, 2
patients were diagnosed with MDD in full remission), the present study must be regarded as from
an atypical sample of cancer patients with a history
of psychiatric disorders.
Copyright r 2009 John Wiley & Sons, Ltd.

It should be noted that the current study suﬀered
from the small sample size. Accordingly, limitations in statistical power do exist. As a result, it is
possible that we were unable to detect diﬀerences
between the sample groups that could have had an
eﬀect on the primary results (e.g. diﬀerences in
ethnic makeup and chemotherapy administration).
In order to address the present limitation, future
research will need to enlist larger, more representative samples.
The ﬁeld of psycho-oncology has struggled with
the problem of screening for psychological diﬃculties with cancer patients. This has largely stemmed
from the shortage of instruments that have been
designed and normed speciﬁcally for use with
cancer patients. The PCM 1.0 Acute Distress and
Despair scales oﬀer a cancer patient-speciﬁc
Psycho-Oncology 19: 399–407 (2010)
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Table 3. Receiver operating characteristics T score cut points for optimum sensitivity and specificity using PCM 1.0 acute distress
and despair scales to identify cancer patients with current major depression determined by Structured Clinical Interview for DSM IV
Axis I Disorders
T score cut point 1 Minus specificity Sensitivity Youden’s Index True positive True negative False positive False negative
Acute Distress Scale
65.56
64.36
63.61
61.03
59.59
58.21
57.26

0.08
0.08
0.12
0.16
0.24
0.28
0.32

0.82
0.88
0.88
1.00
1.00
1.00
1.00

0.74
0.80
0.76
0.84a
0.76
0.72
0.68

14
15
15
17
17
17
17

23
23
22
21
19
18
17

2
2
3
4
6
7
8

3
2
2
0
0
0
0

Despair Scale
65.59
64.71
63.71
62.96
61.43
60.80
60.22

0.12
0.12
0.16
0.16
0.24
0.28
0.32

0.82
0.88
0.88
0.94
0.94
0.94
0.94

0.70
0.76
0.72
0.78a
0.70
0.66
0.62

14
15
15
16
16
16
16

22
22
21
21
19
18
17

3
3
4
4
6
7
8

3
2
2
1
1
1
1

a

Optimal T score cut point indicated by maximum value of Youden’s Index.

approach to screening for potential cases of
depression. Additional inquiry is required to assess
for the ability of these scales to detect possible
cases of anxiety.

11.

12.

References
1. Evans DL, Charney DS, Lewis L et al. Mood disorders
in the medically ill: scientiﬁc review and recommendations. Biol Psychiatry 2005;58(3):175–189.
2. Simon AE, Palmer SC, Coyne JC. Cancer and depression.
In Depression and Physical Illness, Steptoe A (ed.).
Cambridge University Press: Cambridge, 2007:211–237.
3. Coyne JC, Palmer SC, Shapiro PJ, Thompson R,
DeMichele A. Distress, psychiatric morbidity, and
prescriptions for psychotropic medication in a breast
cancer waiting room sample. Gen Hosp Psychiatry
2004;26(2):121–128.
4. Kessler RC, Berglund P, Demler O et al. The
epidemiology of major depressive disorder: results from
the National Comorbidity Survey Replication (NCS-R).
J Am Med Assoc 2003;289(23):3095–3105.
5. Palmer SC, Kagee A, Coyne JC, DeMichele A.
Experience of trauma, distress, and posttraumatic stress
disorder among breast cancer patients. Psychosom Med
2004;66(2):258–264.
6. Clark LA, Watson D. Tripartite model of anxiety and
depression: psychometric evidence and taxonomic
implications. J Abnorm Psychol 1991;100(3):316–336.
7. Bultz BD, Carlson LE. Emotional distress: the sixth
vital sign—future directions in cancer care. PsychoOncology 2006;15(2):93–95.
8. Jacobsen PB, Donovan KA, Trask PC et al. Screening
for psychologic distress in ambulatory cancer patients.
Cancer 2005;103(7):1494–1502.
9. National Comprehensive Cancer Network (NCCN).
NCCN Clinical Practice Guidelines in Oncology:
Distress Management, ed. v.1.2008: National Comprehensive Cancer Network, Inc., 2007.
10. Mitchell AJ, Kaar S, Coggan C, Herdman J. Acceptability of common screening methods used to detect
distress and related mood disorders-preferences of
Copyright r 2009 John Wiley & Sons, Ltd.

13.

14.

15.

16.

17.

18.
19.
20.

21.

cancer specialists and non-specialists. Psycho-Oncology
2008;17(3):226–236.
Clark K, Bardwell WA, Arsenault T, Deteresa R,
Loscalzo M. Implementing touch-screen technology to
enhance recognition of distress. Psycho-Oncology 2008.
DOI: 10.1002/pon.1509.
Allenby A, Matthews J, Beresford J, McLachlan SA. The
application of computer touch-screen technology in screening
for psychosocial distress in an ambulatory oncology
setting. Eur J Cancer Care (Engl ) 2002;11(4):245–253.
Cull A, Gould A, House A et al. Validating automated
screening for psychological distress by means of
computer touchscreens for use in routine oncology
practice. Br J Cancer 2001;85(12):1842–1849.
Velikova G, Wright EP, Smith AB et al. Automated
collection of quality-of-life data: a comparison of paper
and computer touch-screen questionnaires. J Clin Oncol
1999;17(3):998–1007.
Fortner B, Baldwin S, Schwartzberg L et al. Validation
of the Cancer Care Monitor items for physical
symptoms and treatment side eﬀects using expert
oncology nurse evaluation. J Pain Symptom Manage
2006;31(3):207–214.
Fortner B, Okon T, Schwartzberg L, Tauer K, Houts AC.
The Cancer Care Monitor: psychometric content evaluation and pilot testing of a computer administered system
for symptom screening and quality of life in adult cancer
patients. J Pain Symptom Manage 2003;26(6):1077–1092.
First MB, Spitzer RL, MG, Williams JBW. Structured
Clinical Interview for DSM-IV Axis I Disorders,
Research Version, Non-patient Edition. (SCID-I/NP).
Biometrics Research, New York State Psychiatric
Institute, 1997.
Derogatis L. Brief Symptom Inventory: Adminstration,
Scoring, and Procedures Manual (3rd edn). National
Computer Systems, Inc: Minneapolis, 1993.
Ware JE, Kosinski MA. SF-36 Physical and Mental
Health Summary Scales: A Manual for Users of Version
1 (2nd edn). QualityMetric, Inc: Lincoln, RI, 2001.
Ware JE, Snow KK, Kosinski M, Gandek B. SF-36
Health Survey: Manual and Interpretation Guide. The
Health Institute New England Medical Center:Boston,
1993.
Portenoy RK, Thaler HT, Kornblith AB et al. The
memorial symptom assessment scale: an instrument for
Psycho-Oncology 19: 399–407 (2010)
DOI: 10.1002/pon

PCM and depression

22.
23.
24.
25.

the evaluation of symptom prevalence, characteristics
and distress. Eur J Cancer 1994;30A(9):1326–1336.
Bigot A. The relevance of American life satisfaction
indices for research on British subjects before and after
retirement. Age Aging 1974;3(2):113–121.
Neugarten BL, Havinghurst RJ, Tobin SS. The
measurement of life satisfaction. J Gerontol 1961;16:
134–143.
Diener E. Subjective well-being the science of happiness
and a proposal for a national index. Am Psychol
2000;55:34–43.
Diener E, Emmons RA, Larsen RJ, Griﬃn S. The
satisfaction with life scale. J Pers Assess 1985;49:71–75.

Copyright r 2009 John Wiley & Sons, Ltd.

407

26. American Psychiatric Association. Diagnostic and
Statistical Manual of Mental Disorders (4th ed. Text
Revision) (DSM-IV-TR). American Psychiatric Association: Washington, DC, 2000.
27. First MB, Gibbon M, Spitzer RL, Williams JBW. User’s
Guide for the Structured Clinical Interview for DSM-IV
Axis I Disorders: Research Version (SCID-I, Version 2.0
February 1996 Final Version). Biometrics Research:
New York, 1996.
28. Youden WJ. Index for rating diagnostic tests. Cancer
1950;3(1):32–35.
29. Fleiss JL. Statistical Methods for Rates and Proportions
(2nd edn). Wiley: New York, 1981.

Psycho-Oncology 19: 399–407 (2010)
DOI: 10.1002/pon

